ISSN: 1528-9117

Journal Home

Journal Guideline

Cancer Journal Q2 Unclaimed

Lippincott Williams and Wilkins Ltd. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cancer Journal is a journal indexed in SJR in Oncology and Cancer Research with an H index of 102. It has an SJR impact factor of 0,933 and it has a best quartile of Q2. It has an SJR impact factor of 0,933.

Cancer Journal focuses its scope in these topics and keywords: cancer, pancreatic, adolescents, young, care, oral, early, adults, health, imaging, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q2) Oncology (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,933

SJR Impact factor

102

H Index

55

Total Docs (Last Year)

218

Total Docs (3 years)

3810

Total Refs

493

Total Cites (3 years)

200

Citable Docs (3 years)

2.51

Cites/Doc (2 years)

69.27

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

International Journal of Oncology Q2
BMC Cancer Q2
Cancer Epidemiology Q2
Frontiers in Oncology Q2
Journal of Geriatric Oncology Q2

Compare this journals

Aims and Scope

Best articles by citations

The Tumor Microenvironment Regulates CD19 and CD20 Immunotherapy for Lymphoma

Comparing the Use of Protons and Carbon Ions for Treatment

Survival Disparities in Non-Small Cell Lung Cancer by Race, Ethnicity, and Socioeconomic Status

Learning Culture and Outcomes Measurement Practices in Community Agencies

Tumor-Infiltrating Lymphocytes

Performance Measurement Redux

Targeting Outcomes of Programs (), edited by Dr. Kay Rockwell of the University of Nebraska, Lincoln and Dr. Claude Bennett of the Cooperative State Research, Education and Extension Service, USDA

Building a Better Body of Evidence: New Opportunities to Strengthen Evaluation Utilization

Evaluation of the Ft. Bragg and Stark County Systems of Care for Children and Adolescents

Development of a national evaluation system to evaluate CDC-funded health department HIV prevention programs

Recovery Issues in Cancer Survivorship

Lessons From 30 Years of Teaching About the Microenvironment of Tumors

SHOW MORE ARTICLES

Genomic Strategies to Personalize Use of Androgen Deprivation Therapy With Radiotherapy

Presidential address: building evaluation's collective capacity

Presidential Address: On Mainstreaming Evaluation

Chimeric Antigen Receptor T Cells in Chronic Lymphocytic Leukemia

Imaging Mouse Models of Cancer

Next Generation of Androgen Deprivation Therapy Combined With Radiotherapy for N0 M0 Prostate Cancer

Repurposing Drugs for Cancer Radiotherapy

An Exploratory Study of Process Use: Findings and Implications for Future Research

Practical Aspects of Pediatric Proton Radiation Therapy

Unequal Power - Changing Landscapes: Negotiations between Evaluation Stakeholders in Latino Communities

Hepatic Artery Embolization and Chemoembolization for Treatment of Patients with Metastatic Carcinoid Tumors

Evaluation Training at Northwestern (And Beyond?): Sages, Golden Ages, and Stages